Over the last few years, a trend has been occurring which shows a clear globalization of the research and development process. While the United States is still the clear-cut leader in the category of drug and medical R&D, more companies based in the U.S. are looking abroad to foreign countries to research their product. Doing so creates a new area of risk that must be insured. Hays Companies has an experienced international team that manages local insurance placements that have been used by a multitude of businesses including Fortune 500 companies. Using our global insurer partners and our connections through the Worldwide Broker Network, Hays has the means and tools to help manage locally admitted insurance for foreign clinical trials. Click the link for more details on Foreign Clinical Trials Coverage.